The Asian Pacific Association for the Study of the Liver [APASL]

Monthly News

APASL STC on HCV in Kaohsiung is coming soon!

Message from APASL Single Topic Conference in Kaohsiung

APASL STC on HCV in Taiwan

Date: June 10-12, 2016
City: Kaohsiung, Taiwan
Venue: Kaohsiung Exhibition Center
President: Dr. Wan-Long Chuang

Message from APASL2017 in Shanghai

Dear Colleagues,

We are delighted and honored to introduce you to the 26th Conference of the Asian Pacific Association for the Study of the Liver (APASL), which will take place at Shanghai International Convention Center, on 16-19 February 2017 in Shanghai, China. We will bring together a distinguished faculty of renowned specialists from Asia Pacific and around the world to this conference.

APASL annual meeting has grown as the leading conference focusing on remarkable progress in liver disease, aimed to provide the latest scientific and evidence-based research result that will be applicable to the everyday clinical practice. It provides an excellent opportunity to share and exchange experiences especially from the view of Asian Pacific countries. These elements are essential to pave a way for better development of Hepatology.

We planned to have a three-day core program to provide an overview of varies liver diseases with the State-of- the Art Lectures on hot-off-the-press issues. Besides, Postgraduate Courses and Morning Sessions will be de- signed for the in-depth discussion on particular topics.

Free paper and poster presentation is always the soul of the conference to share research findings and there will be several awards available for application aimed to support young scientists to attend the conference and encourage scientific research.

We thus enthusiastically invite you to submit abstract and join us in this conference as well as our blooming city – Shanghai.

We look forward to welcoming you in Shanghai!

Prof. Jinlin Hou

President of APASL2017

Message from the Organizer of APASL STC 2016 in Turkey

Dear Colleagues,

I am honored to invite you to the single topic conference on Non Responders that will be held in Istanbul on 22-24 September 2016. Such problems as the exposure of patients to cirrhosis of the liver, and its complications due to the unresponsiveness of chronic hepatitis B, C, and delta infections, to the current treatments; the development of hepatocellular carcinoma; and recurrence of infections following liver transplantation continue to be challenging issues in today's world. New research with respect to patients with chronic hepatitis and who do not respond, specifically to the treatments specified in the treatment guidelines, will be presented, and interactive discussions will be held with the world's opinion leaders on hepatology.

At the same time, the similarities and differences (if any) in terms of treatment between the East and the West will be debated. In particular, the steadily increasing trends in cirrhosis of the liver and hepatocellular cancer rates dependent on the unresponsiveness of the hepatitis C virus, between 2020-2030, will be confronted. For this reason, the treatment of compensated and/or decompensated cirrhosis of the liver being unresponsive or partially responsive to previous treatments or those developing dependent on relapses following treatment will continue to be a globally significant health problem.

Following the discovery of the Neolithic settlement during excavations in Yenikapı (the ancient port of Theodosius) it is now understood that the origins of Istanbul date back at least 8,500 years. The city of Istanbul was known as Byzantium by the Greeks in 700 BCE; as Constantinople it was the capital of the Roman and Eastern Roman Empires. Following the conquest of the city by the Ottoman Empire in 1453, the city remained the capital of the Ottoman Empire for almost five centuries, and was known to the Turks as Istanbul.

Among the most important monuments defining the culture and identity of the city are, the Hippodrome, the Basilica Cistern and the Column of Constantine date, which date from Roman times. Then there is the Galata Tower but by the Genoese, and of course, Haghia Sophia, which still stands as the most important testament to the Byzantine age in the world after 1500 years. Then there are the Ottoman buildings, such as the Topkapı Palace, for centuries the residence of the Ottoman sultans and the administrative center, together with more than 80 museums and 9 other Ottoman palaces. The Sultanahmet Mosque and Süleymaniye Mosque and superb examples of Ottoman religious architecture and the Grand Bazaar and Spice Market (Kapalıçarşı and Mısır Çarşısı), both still going strong today, continue the commercial tradition, for which Istanbul is so famous.

Istanbul’s cultural heritage has given the city international importance: in 2010 it was the European Capital of Culture and it is now included in the UNESCO World Heritage List. With its historical and natural beauties, bridges and underwater tunnel connecting the Asian and European continents, Istanbul shines like pearl on the Bosphorus.

Its ancient history and five centuries as the capital of the Ottoman Empire mean that alongside its own cultural wealth and culinary diversity, Istanbul embraces the illustrious cuisines of Asia, Europe and Africa. Turkish cuisine, now only second to Chinese in terms of popularity, celebrates its huge range of dishes, amazingly there are more than 400 varieties of dessert alone, and all of them are distinctive and delicious.

I would like to conclude by saying how I will be more than pleased to be your host in Istanbul, offering you the finest Traditional Ottoman Hospitality on the occasion of this scientifically rich program.

Kind regards,

  • Prof. A. Kadir DOKMECİ, MD
    Honorary President
  • Prof. Necati ORMECİ, MD
    Congress President
  • Prof. Hasan OZKAN, MD
    Congress Secretary General

APASL STC on Non-Responders in Turkey

Date: September 22-24, 2016
City: Istanbul, Turkey
President: Dr. Necati Ormeci

Future APASL Single Topic Conferences

APASL STC on HBV in China

Date: December 16-18, 2016
City: Beijing, China
President: Dr. Lai Wei
Website: To be announced.

APASL STC on Prevention of HCC development in Japan

Date: April 10-12, 2017
City: Nagasaki, Japan
President: Dr. Hiroshi Yatsuhashi

APASL STC on HCV and coinfection in Mongolia

Date: To be announced.
City: Ulaanbaatar, Mongolia
President: Dr. Oidov Baatarkhuu

APASL STC on HCV in Cairo, Egypt

Date: September 6-8, 2017
City: Cairo, Egypt
President: Dr. Gamal Shiha

APASL 2018 Annual Meeting in India

Date: March 15-18, 2018
City: New Delhi, India
President: Dr. Barjesh C. Sharma

APASL 2019 Annual Meeting in Philippines

Date: To be announced.
City: Manila, Philippines
President: Dr. Diana A. Payawal

Global Summit in EASL 2016

The Joint Society Statement for Elimination of Viral Hepatitis has been signed and shared with WHO, ‪EASL, AASLD, and ALEH!

The Joint Society Statement for Elimination of Viral Hepatitis

APASL Fellowship 2017

The objective of the fellowship is to foster career development by encouraging the beneficial experience of working in a different clinical or research environment in another country in the Asia-Pacific region. These fellowships provide for advanced training in health and medical research in any country in the Asia-Pacific region and enable fellows to work in a clinical environment or on a research project with nominated advisers. We appreciate your generous contributions and support for these APASL fellowships and look forward to a number of high-quality applications for a 2017 fellowship.

An application form can be downloaded by clicking here: Please fill in and send to the APASL secretariat ( We are looking forward to receiving your application. There are no restrictions based on nationality. The sponsoring institution with the academic environment to provide adequate support for the proposed project might be suggested by APASL. Application will be reviewed by APASL Committee members. The decisions of the Committee are final and not subject to appeal.